Has Suketu Khandhar, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,974 in general payments to Suketu Khandhar, MD across 27 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Suketu Khandhar, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Suketu Khandhar, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Suketu Khandhar, MD

Neurology · Sacramento, CANPI 1902984446

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.3% of the total across 27 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Boston Scientific accounts for 67.9% of it on its own, with 5 other manufacturers making up the rest.

$1,974in general payments, 2019–2025

Across 27 payments — averaging $73.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$1K
Medtronic$270
Insightec,inc$146
AbbVie$97
Sunovion Pharmaceuticals Inc.$61
Abbott$59

$35,523in research payments, 2019–2025

Across 23 payments — averaging $1544.49 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Boston Scientific$20K
Abbott$15K

What the payments were for

Travel & lodging$312%
Food & beverage$1,88295%
Education$613%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	17	$1,341
Medtronic(2 entities)	4	$270
Insightec,inc	1	$146
AbbVie	3	$97
Sunovion Pharmaceuticals Inc.	1	$61
Abbott	1	$59

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,974 in reported general payments places this provider in the 55th percentile of 1,996 neurology providers in California.

See all neurology providers in California →

Medicare billing

Part B allowed, 2024

$2,107

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
AustedoDeutetrabenazine	61	$447,694
NuplazidPimavanserin Tartrate	42	$218,217
RytaryCarbidopa/Levodopa	72	$159,024
IngrezzaValbenazine Tosylate	18	$155,019
InbrijaLevodopa	67	$154,919
Avonex Pen (4 Pack)Interferon Beta-1a	13	$104,315
XadagoSafinamide Mesylate	26	$100,189
Carbidopa-LevodopaCarbidopa/Levodopa	1,213	$82,727
NeuproRotigotine	52	$67,331
GocovriAmantadine Hcl	24	$43,493
HorizantGabapentin Enacarbil	11	$24,626
Droxidopa	24	$19,658
Carbidopa-Levodopa ErCarbidopa/Levodopa	345	$15,081
OngentysOpicapone	13	$13,130
Carbidopa	35	$10,888

Paid to pharmacies, not to this prescriber.

Other neurology in Sacramento

Lin ZhangSacramento$328K
Andrew BlumenfeldCarlsbad$4.9M
Khashayar DashtipourLoma Linda$3.3M
Regina BerkovichWest Hollywood$3M
Daniel BandariNewport Beach$2.6M
Perry ShiehLos Angeles$2.4M
Sandeep ThakkarIrvine$2M
David LiebeskindLos Angeles$1.9M
Jack SchimCarlsbad$1.7M
Parshaw DorrizMission Viejo$1.5M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →